Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Malignant tumors in autoimmune encephalitis with anti-NMDA receptor antibodies.

Bost C, Chanson E, Picard G, Meyronet D, Mayeur ME, Ducray F, Rogemond V, Psimaras D, Antoine JC, Delattre JY, Desestret V, Honnorat J.

J Neurol. 2018 Jul 12. doi: 10.1007/s00415-018-8970-0. [Epub ahead of print]

PMID:
30003358
2.

Multiplex family with GAD65-Abs neurologic syndromes.

Belbezier A, Joubert B, Montero-Martin G, Fernandez-Vina M, Fabien N, Rogemond V, Mignot E, Honnorat J.

Neurol Neuroimmunol Neuroinflamm. 2017 Dec 5;5(1):e416. doi: 10.1212/NXI.0000000000000416. eCollection 2018 Jan.

3.

Effect of thymectomy on refractory autoimmune status epilepticus.

Vogrig A, Pauletto G, Belgrado E, Pegolo E, Di Loreto C, Rogemond V, Honnorat J, Eleopra R.

J Neuroimmunol. 2018 Apr 15;317:90-94. doi: 10.1016/j.jneuroim.2018.01.009. Epub 2018 Jan 9.

PMID:
29336839
4.

Initial clinical presentation of young children with N-methyl-d-aspartate receptor encephalitis.

Favier M, Joubert B, Picard G, Rogemond V, Thomas L, Rheims S, Bailhache M, Villega F, Pédespan JM, Berzero G, Psimaras D, Antoine JC, Desestret V, Honnorat J.

Eur J Paediatr Neurol. 2018 May;22(3):404-411. doi: 10.1016/j.ejpn.2017.12.014. Epub 2017 Dec 28.

PMID:
29310866
5.

Complex HLA association in paraneoplastic cerebellar ataxia with anti-Yo antibodies.

Hillary RP, Ollila HM, Lin L, Desestret V, Rogemond V, Picard G, Small M, Arnulf I, Dauvilliers Y, Honnorat J, Mignot E.

J Neuroimmunol. 2018 Feb 15;315:28-32. doi: 10.1016/j.jneuroim.2017.12.012. Epub 2017 Dec 18.

PMID:
29306402
6.

Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration.

Small M, Treilleux I, Couillault C, Pissaloux D, Picard G, Paindavoine S, Attignon V, Wang Q, Rogemond V, Lay S, Ray-Coquard I, Pfisterer J, Joly F, Du Bois A, Psimaras D, Bendriss-Vermare N, Caux C, Dubois B, Honnorat J, Desestret V.

Acta Neuropathol. 2018 Apr;135(4):569-579. doi: 10.1007/s00401-017-1802-y. Epub 2018 Jan 3.

PMID:
29299667
7.

Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients.

Jézéquel J, Johansson EM, Dupuis JP, Rogemond V, Gréa H, Kellermayer B, Hamdani N, Le Guen E, Rabu C, Lepleux M, Spatola M, Mathias E, Bouchet D, Ramsey AJ, Yolken RH, Tamouza R, Dalmau J, Honnorat J, Leboyer M, Groc L.

Nat Commun. 2017 Nov 27;8(1):1791. doi: 10.1038/s41467-017-01700-3.

8.

Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies.

Berzero G, Karantoni E, Dehais C, Ducray F, Thomas L, Picard G, Rogemond V, Candelier G, Camdessanché JP, Antoine JC, De Seze J, Liou-Schischmanoff A, Honnorat J, Delattre JY, Psimaras D.

J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):789-792. doi: 10.1136/jnnp-2017-316904. Epub 2017 Oct 30. No abstract available.

9.

Cell- and Single Molecule-Based Methods to Detect Anti-N-Methyl-D-Aspartate Receptor Autoantibodies in Patients With First-Episode Psychosis From the OPTiMiSE Project.

Jézéquel J, Rogemond V, Pollak T, Lepleux M, Jacobson L, Gréa H, Iyegbe C, Kahn R, McGuire P, Vincent A, Honnorat J, Leboyer M, Groc L.

Biol Psychiatry. 2017 Nov 15;82(10):766-772. doi: 10.1016/j.biopsych.2017.06.015. Epub 2017 Jul 6.

PMID:
28780967
10.

Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis.

Joubert B, Gobert F, Thomas L, Saint-Martin M, Desestret V, Convers P, Rogemond V, Picard G, Ducray F, Psimaras D, Antoine JC, Delattre JY, Honnorat J.

Neurol Neuroimmunol Neuroinflamm. 2017 Jun 14;4(4):e371. doi: 10.1212/NXI.0000000000000371. eCollection 2017 Jul.

11.

Clinical and autoimmune features of a patient with autism spectrum disorder seropositive for anti-NMDA-receptor autoantibody.

Gréa H, Scheid I, Gaman A, Rogemond V, Gillet S, Honnorat J, Bolognani F, Czech C, Bouquet C, Toledano E, Bouvard M, Delorme R, Groc L, Leboyer M.

Dialogues Clin Neurosci. 2017 Mar;19(1):65-70.

12.

Characteristics in limbic encephalitis with anti-adenylate kinase 5 autoantibodies.

Do LD, Chanson E, Desestret V, Joubert B, Ducray F, Brugière S, Couté Y, Formaglio M, Rogemond V, Thomas-Antérion C, Borrega L, Laurens B, Tison F, Curot J, De Brouker T, Lebrun-Frenay C, Delattre JY, Antoine JC, Honnorat J.

Neurology. 2017 Feb 7;88(6):514-524. doi: 10.1212/WNL.0000000000003586. Epub 2017 Jan 6.

PMID:
28062719
13.

Neuroleptic intolerance in patients with anti-NMDAR encephalitis.

Lejuste F, Thomas L, Picard G, Desestret V, Ducray F, Rogemond V, Psimaras D, Antoine JC, Delattre JY, Groc L, Leboyer M, Honnorat J.

Neurol Neuroimmunol Neuroinflamm. 2016 Aug 29;3(5):e280. doi: 10.1212/NXI.0000000000000280. eCollection 2016 Oct.

14.

Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Adult Patients Requiring Intensive Care.

de Montmollin E, Demeret S, Brulé N, Conrad M, Dailler F, Lerolle N, Navellou JC, Schwebel C, Alves M, Cour M, Engrand N, Tonnelier JM, Maury E, Ruckly S, Picard G, Rogemond V, Magalhaes É, Sharshar T, Timsit JF, Honnorat J, Sonneville R; ENCEPHALITICA Study Group ‡.

Am J Respir Crit Care Med. 2017 Feb 15;195(4):491-499. doi: 10.1164/rccm.201603-0507OC.

PMID:
27552490
15.

Characterization of a Subtype of Autoimmune Encephalitis With Anti-Contactin-Associated Protein-like 2 Antibodies in the Cerebrospinal Fluid, Prominent Limbic Symptoms, and Seizures.

Joubert B, Saint-Martin M, Noraz N, Picard G, Rogemond V, Ducray F, Desestret V, Psimaras D, Delattre JY, Antoine JC, Honnorat J.

JAMA Neurol. 2016 Sep 1;73(9):1115-24. doi: 10.1001/jamaneurol.2016.1585.

PMID:
27428927
16.

Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis.

Navarro V, Kas A, Apartis E, Chami L, Rogemond V, Levy P, Psimaras D, Habert MO, Baulac M, Delattre JY, Honnorat J; collaborators.

Brain. 2016 Apr;139(Pt 4):1079-93. doi: 10.1093/brain/aww012. Epub 2016 Mar 5.

PMID:
26945884
17.

CSF IgA NMDAR antibodies are potential biomarkers for teratomas in anti-NMDAR encephalitis.

Desestret V, Chefdeville A, Viaccoz A, Bost C, Ducray F, Picard G, Rogemond V, Chaffois MO, Blanc C, Bardel C, Treilleux I, Pascual O, Antoine JC, Delattre JY, Honnorat J.

Neurol Neuroimmunol Neuroinflamm. 2015 Oct 29;2(6):e166. doi: 10.1212/NXI.0000000000000166. eCollection 2015 Dec.

18.

Clinical Spectrum of Encephalitis Associated With Antibodies Against the α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor: Case Series and Review of the Literature.

Joubert B, Kerschen P, Zekeridou A, Desestret V, Rogemond V, Chaffois MO, Ducray F, Larrue V, Daubail B, Idbaih A, Psimaras D, Antoine JC, Delattre JY, Honnorat J.

JAMA Neurol. 2015 Oct;72(10):1163-9. doi: 10.1001/jamaneurol.2015.1715. Review.

PMID:
26280228
19.

Inhibitory axons are targeted in hippocampal cell culture by anti-Caspr2 autoantibodies associated with limbic encephalitis.

Pinatel D, Hivert B, Boucraut J, Saint-Martin M, Rogemond V, Zoupi L, Karagogeos D, Honnorat J, Faivre-Sarrailh C.

Front Cell Neurosci. 2015 Jul 9;9:265. doi: 10.3389/fncel.2015.00265. eCollection 2015.

20.

Treatment and outcome of children and adolescents with N-methyl-D-aspartate receptor encephalitis.

Zekeridou A, Karantoni E, Viaccoz A, Ducray F, Gitiaux C, Villega F, Deiva K, Rogemond V, Mathias E, Picard G, Tardieu M, Antoine JC, Delattre JY, Honnorat J.

J Neurol. 2015 Aug;262(8):1859-66. doi: 10.1007/s00415-015-7781-9. Epub 2015 May 19.

PMID:
25987208
21.

Standardized test for anti-Tr/DNER in patients with paraneoplastic cerebellar degeneration.

Probst C, Komorowski L, de Graaff E, van Coevorden-Hameete M, Rogemond V, Honnorat J, Sabeter L, Graus F, Jarius S, Voltz R, Wildemann B, Franciotta D, Blöcker IM, Schlumberger W, Stöcker W, Sillevis Smitt PA.

Neurol Neuroimmunol Neuroinflamm. 2015 Feb 26;2(2):e68. doi: 10.1212/NXI.0000000000000068. eCollection 2015 Apr.

22.

Antifibroblast growth factor receptor 3 antibodies identify a subgroup of patients with sensory neuropathy.

Antoine JC, Boutahar N, Lassablière F, Reynaud E, Ferraud K, Rogemond V, Paul S, Honnorat J, Camdessanché JP.

J Neurol Neurosurg Psychiatry. 2015 Dec;86(12):1347-55. doi: 10.1136/jnnp-2014-309730. Epub 2015 Jan 27.

PMID:
25628376
23.

Intrathecal treatment of anti-N-Methyl-D-aspartate receptor encephalitis in children.

Tatencloux S, Chretien P, Rogemond V, Honnorat J, Tardieu M, Deiva K.

Dev Med Child Neurol. 2015 Jan;57(1):95-9. doi: 10.1111/dmcn.12545. Epub 2014 Jul 16.

24.

Surface dynamics of GluN2B-NMDA receptors controls plasticity of maturing glutamate synapses.

Dupuis JP, Ladépêche L, Seth H, Bard L, Varela J, Mikasova L, Bouchet D, Rogemond V, Honnorat J, Hanse E, Groc L.

EMBO J. 2014 Apr 16;33(8):842-61. doi: 10.1002/embj.201386356. Epub 2014 Mar 3.

25.

Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis.

Viaccoz A, Desestret V, Ducray F, Picard G, Cavillon G, Rogemond V, Antoine JC, Delattre JY, Honnorat J.

Neurology. 2014 Feb 18;82(7):556-63. doi: 10.1212/WNL.0000000000000126. Epub 2014 Jan 17.

PMID:
24443452
26.

Autoimmune N-methyl-D-aspartate receptor encephalitis is a differential diagnosis of infectious encephalitis.

Thomas L, Mailles A, Desestret V, Ducray F, Mathias E, Rogemond V, Didelot A, Marignier S, Stahl JP, Honnorat J; Steering Committee and Investigators Group.

J Infect. 2014 May;68(5):419-25. doi: 10.1016/j.jinf.2013.12.001. Epub 2013 Dec 17.

PMID:
24355654
27.

Collapsin response mediator protein 5 (CRMP5) induces mitophagy, thereby regulating mitochondrion numbers in dendrites.

Brot S, Auger C, Bentata R, Rogemond V, Ménigoz S, Chounlamountri N, Girard-Egrot A, Honnorat J, Moradi-Améli M.

J Biol Chem. 2014 Jan 24;289(4):2261-76. doi: 10.1074/jbc.M113.490862. Epub 2013 Dec 9.

28.

An ion channel chip for diagnosis and prognosis of autoimmune neurological disorders.

Chatelain FC, Mazzuca M, Larroque MM, Rogemond V, Honnorat J, Lesage F.

Recent Pat CNS Drug Discov. 2013 Dec;8(3):171-9.

PMID:
24050250
29.

Mapping CRMP3 domains involved in dendrite morphogenesis and voltage-gated calcium channel regulation.

Quach TT, Wilson SM, Rogemond V, Chounlamountri N, Kolattukudy PE, Martinez S, Khanna M, Belin MF, Khanna R, Honnorat J, Duchemin AM.

J Cell Sci. 2013 Sep 15;126(Pt 18):4262-73. doi: 10.1242/jcs.131409. Epub 2013 Jul 18.

30.

Dramatic improvement after rituximab in a patient with paraneoplastic treatment-refractory Morvan syndrome associated with anti-CASPR2 antibodies.

Ong E, Viaccoz A, Ducray F, Pérol M, Cavillon G, Rogemond V, Honnorat J, Petiot P.

Eur J Neurol. 2013 Jul;20(7):e96-7. doi: 10.1111/ene.12164. No abstract available.

PMID:
23750840
31.

Autoimmune limbic encephalopathy and anti-Hu antibodies in children without cancer.

Honnorat J, Didelot A, Karantoni E, Ville D, Ducray F, Lambert L, Deiva K, Garcia M, Pichit P, Cavillon G, Rogemond V, DeLattre JY, Tardieu M.

Neurology. 2013 Jun 11;80(24):2226-32. doi: 10.1212/WNL.0b013e318296e9c3. Epub 2013 May 8.

PMID:
23658383
32.

Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity.

Marignier R, Bernard-Valnet R, Giraudon P, Collongues N, Papeix C, Zéphir H, Cavillon G, Rogemond V, Casey R, Frangoulis B, De Sèze J, Vukusic S, Honnorat J, Confavreux C; NOMADMUS Study Group.

Neurology. 2013 Jun 11;80(24):2194-200. doi: 10.1212/WNL.0b013e318296e917. Epub 2013 May 8.

PMID:
23658379
33.

Identification of a new CRMP5 isoform present in the nucleus of cancer cells and enhancing their proliferation.

Brot S, Malleval C, Benetollo C, Auger C, Meyronet D, Rogemond V, Honnorat J, Moradi-Améli M.

Exp Cell Res. 2013 Mar 10;319(5):588-99. doi: 10.1016/j.yexcr.2012.12.011. Epub 2013 Jan 5.

PMID:
23298946
34.

Opsoclonus, limbic encephalitis, anti-Ma2 antibodies and gastric adenocarcinoma.

Biotti D, Viaccoz A, Olivier N, Tilikete C, Rogemond V, Honnorat J, Vighetto A.

Eur J Neurol. 2012 Dec;19(12):e144-5. doi: 10.1111/j.1468-1331.2012.03881.x. No abstract available.

PMID:
23157246
35.

Drug binding assays do not reveal specific binding of lacosamide to collapsin response mediator protein 2 (CRMP-2).

Wolff C, Carrington B, Varrin-Doyer M, Vandendriessche A, Van der Perren C, Famelart M, Gillard M, Foerch P, Rogemond V, Honnorat J, Lawson A, Miller K.

CNS Neurosci Ther. 2012 Jun;18(6):493-500. doi: 10.1111/j.1755-5949.2012.00313.x.

PMID:
22672303
36.

Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis.

Mikasova L, De Rossi P, Bouchet D, Georges F, Rogemond V, Didelot A, Meissirel C, Honnorat J, Groc L.

Brain. 2012 May;135(Pt 5):1606-21. doi: 10.1093/brain/aws092.

PMID:
22544902
37.

Full recovery of agrypnia associated with anti-Lgi1 antibodies encephalitis under immunomodulatory treatment: a case report with sequential polysomnographic assessment.

Peter-Derex L, Devic P, Rogemond V, Rheims S, Mauguière F, Honnorat J.

Sleep Med. 2012 May;13(5):554-6. doi: 10.1016/j.sleep.2012.01.002. Epub 2012 Mar 19. No abstract available.

PMID:
22437141
38.

Anti-N-methyl-D-aspartate receptor encephalitis with acute disseminated encephalomyelitis-like MRI features.

Lekoubou A, Viaccoz A, Didelot A, Anastasi A, Marignier R, Ducray F, Rogemond V, Honnorat J.

Eur J Neurol. 2012 Feb;19(2):e16-7. doi: 10.1111/j.1468-1331.2011.03617.x. Epub 2011 Dec 19. No abstract available.

PMID:
22182357
39.

VEGF modulates NMDA receptors activity in cerebellar granule cells through Src-family kinases before synapse formation.

Meissirel C, Ruiz de Almodovar C, Knevels E, Coulon C, Chounlamountri N, Segura I, de Rossi P, Vinckier S, Anthonis K, Deléglise B, de Mol M, Ali C, Dassonville K, Loyens E, Honnorat J, Michotte Y, Rogemond V, Smolders I, Voets T, Vivien D, Vanden Berghe P, Van den Bosch L, Robberecht W, Chédotal A, Oliviero S, Dewerchin M, Schmucker D, Thomasset N, Salin P, Carmeliet P.

Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13782-7. doi: 10.1073/pnas.1100341108. Epub 2011 Jul 29.

40.

Respective implications of glutamate decarboxylase antibodies in stiff person syndrome and cerebellar ataxia.

Manto MU, Hampe CS, Rogemond V, Honnorat J.

Orphanet J Rare Dis. 2011 Feb 4;6:3. doi: 10.1186/1750-1172-6-3.

41.

In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction.

Manto M, Dalmau J, Didelot A, Rogemond V, Honnorat J.

Orphanet J Rare Dis. 2010 Nov 26;5:31. doi: 10.1186/1750-1172-5-31.

42.

Brain immunohistopathological study in a patient with anti-NMDAR encephalitis.

Camdessanché JP, Streichenberger N, Cavillon G, Rogemond V, Jousserand G, Honnorat J, Convers P, Antoine JC.

Eur J Neurol. 2011 Jun;18(6):929-31. doi: 10.1111/j.1468-1331.2010.03180.x. Epub 2010 Aug 16.

PMID:
20722705
43.

CRMP5 interacts with tubulin to inhibit neurite outgrowth, thereby modulating the function of CRMP2.

Brot S, Rogemond V, Perrot V, Chounlamountri N, Auger C, Honnorat J, Moradi-Améli M.

J Neurosci. 2010 Aug 11;30(32):10639-54. doi: 10.1523/JNEUROSCI.0059-10.2010.

44.

Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury.

Marignier R, Nicolle A, Watrin C, Touret M, Cavagna S, Varrin-Doyer M, Cavillon G, Rogemond V, Confavreux C, Honnorat J, Giraudon P.

Brain. 2010 Sep;133(9):2578-91. doi: 10.1093/brain/awq177. Epub 2010 Aug 5.

PMID:
20688809
45.

Afferent facilitation of corticomotor responses is increased by IgGs of patients with NMDA-receptor antibodies.

Manto M, Dalmau J, Didelot A, Rogemond V, Honnorat J.

J Neurol. 2011 Jan;258(1):27-33. doi: 10.1007/s00415-010-5674-5. Epub 2010 Jul 24.

46.

Delayed onset of a second paraneoplastic neurological syndrome in eight patients.

Ducray F, Graus F, Vigliani MC, Antoine JC, Rogemond V, Saiz A, Honnorat J.

J Neurol Neurosurg Psychiatry. 2010 Aug;81(8):937-9. doi: 10.1136/jnnp.2009.190199. Epub 2010 Jun 18.

47.

HLA-DQ2+ individuals are susceptible to Hu-Ab associated paraneoplastic neurological syndromes.

de Graaf MT, de Beukelaar JW, Haasnoot GW, Levering WH, Rogemond V, Didelot A, Honnorat J, Gratama JW, Smitt PA.

J Neuroimmunol. 2010 Sep 14;226(1-2):147-9. doi: 10.1016/j.jneuroim.2010.05.035. Epub 2010 Jun 12.

PMID:
20547426
48.

Metabotropic glutamate receptor type 1 autoantibody-associated cerebellitis: a primary autoimmune disease?

Marignier R, Chenevier F, Rogemond V, Sillevis Smitt P, Renoux C, Cavillon G, Androdias G, Vukusic S, Graus F, Honnorat J, Confavreux C.

Arch Neurol. 2010 May;67(5):627-30. doi: 10.1001/archneurol.2010.51.

PMID:
20457964
49.

Facial pain as first manifestation of anti-Hu paraneoplastic syndrome.

Demarquay G, Didelot A, Rogemond V, Ryvlin P, Gouttard M, Garassus P, Mauguière F, Honnorat J.

J Headache Pain. 2010 Aug;11(4):355-7. doi: 10.1007/s10194-010-0212-5. Epub 2010 Apr 13.

50.

Collapsin response mediator protein 4a (CRMP4a) is upregulated in motoneurons of mutant SOD1 mice and can trigger motoneuron axonal degeneration and cell death.

Duplan L, Bernard N, Casseron W, Dudley K, Thouvenot E, Honnorat J, Rogemond V, De Bovis B, Aebischer P, Marin P, Raoul C, Henderson CE, Pettmann B.

J Neurosci. 2010 Jan 13;30(2):785-96. doi: 10.1523/JNEUROSCI.5411-09.2010.

Supplemental Content

Loading ...
Support Center